抗癌藥物市場規模、佔有率和趨勢分析報告：按藥物類別、癌症類型、給藥途徑、藥物類型、分銷管道、地區和細分市場預測（2026-2033 年）

Oncology Drugs Market Size, Share & Trends Analysis Report By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy), By Cancer Type, By Route of Administration, By Drug Type, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

出版日期: 2026年08月25日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

抗癌藥物市場概述

預計到 2025 年，全球抗癌藥物市場價值將達到 2,576 億美元，從 2026 年的 2,807 億美元成長到 2033 年的 5,416 億美元，2026 年至 2033 年的複合年成長率為 9.8%。

北美市場處於領先地位，預計到2025年將佔據最大的銷售佔有率，達到41.2%。市場擴張的原因在於全球癌症負擔日益加重、精準醫療的普及以及對創新療法的持續投資。

免疫療法、標靶治療和細胞療法的日益普及正在改善多種腫瘤類型的臨床療效，從而推動市場成長。生物標記檢測和基因組分析技術的進步使得個人化治療方案成為可能，而針對未滿足醫療需求的療法的快速法規核准流程也加速了產品的上市。新興市場醫療保健支出的成長以及癌症診斷和治療可近性的提高進一步刺激了市場需求。

然而，高昂的治療費用、保險報銷難題以及來自學名藥和生物相似藥的價格壓力持續影響著市場趨勢。複雜的臨床開發流程和嚴格的監管要求也影響商業化的步伐。儘管面臨這些挑戰，但持續的研究合作、癌症臨床試驗的增加以及伴隨診斷的更廣泛應用有望加強開發平臺，並為發達和新興醫療市場的持續擴張創造機會。

2025年及2033年區域市佔率分析
區域市場概覽
市場規模、預測與趨勢分析，2021-2033年
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 丹麥
- 瑞典
- 挪威
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 泰國
拉丁美洲
- 巴西
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- UAE
- 科威特

第10章競爭格局

參與企業概況
公司市場分析
公司分類
策略規劃
公司簡介列表
- Roche Holding AG
- Merck & Co., Inc.
- AstraZeneca PLC
- Bristol Myers Squibb
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson
- Eli Lilly and Company
- GSK plc
- Amgen Inc.

簡介目錄圖表

Product Code: GVR-4-68041-001-1

Oncology Drugs Market Summary

The global oncology drugs market size was valued at USD 257.6 billion in 2025 and is projected to grow from USD 280.7 billion in 2026 to USD 541.6 billion by 2033, at a CAGR of 9.8% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 41.2% in 2025. The market is expanding due to the rising global burden of cancer, increasing adoption of precision medicine, and continued investment in innovative therapies.

Growing use of immunotherapies, targeted therapies, and cell-based treatments is improving clinical outcomes across multiple tumor types and supporting market growth. Advances in biomarker testing and genomic profiling are enabling more personalized treatment approaches, while faster regulatory pathways for therapies addressing unmet medical needs are accelerating product launches. Expanding healthcare expenditure and improving access to cancer diagnosis and treatment in emerging economies are further supporting demand.

However, high treatment costs, reimbursement challenges, and pricing pressure from generic and biosimilar products continue to influence market performance. Complex clinical development processes and stringent regulatory requirements also affect the pace of commercialization. Despite these challenges, ongoing research collaborations, an increasing number of oncology clinical trials, and broader integration of companion diagnostics are expected to strengthen the development pipeline and create opportunities for sustained market expansion in both developed and emerging healthcare markets.

Global Oncology Drugs Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oncology drugs market report based on drug class, cancer type, route of administration, drug type, distribution channel, and region:

Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Radiopharmaceuticals
Cell & Gene Therapy
Others
Cancer Type Outlook (Revenue, USD Billion, 2021 - 2033)
Solid Tumors
Hematologic Malignancies
Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
Oral
Injectable
Others
Drug Type Outlook (Revenue, USD Billion, 2021 - 2033)
Branded
Generic & Biosimilar
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Drug Class
- 1.2.2. Cancer Type
- 1.2.3. Route of Administration
- 1.2.4. Drug Type
- 1.2.5. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Oncology Drugs Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.3. Pipeline Analysis
- 3.3.4. Patent Expiry Analysis
- 3.3.5. Pricing Analysis

Chapter 4. Oncology Drugs Market: Drug Class Business Analysis

4.1. Drug Class Market Share, 2025 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
4.4. Chemotherapy
- 4.4.1. Chemotherapy Market, 2021 - 2033 (USD Billion)
4.5. Targeted Therapy
- 4.5.1. Targeted Therapy Market, 2021 - 2033 (USD Billion)
4.6. Immunotherapy
- 4.6.1. Immunotherapy Market, 2021 - 2033 (USD Billion)
4.7. Hormonal Therapy
- 4.7.1. Hormonal Therapy Market, 2021 - 2033 (USD Billion)
4.8. Radiopharmaceuticals
- 4.8.1. Radiopharmaceuticals Market, 2021 - 2033 (USD Billion)
4.9. Cell & Gene Therapy
- 4.9.1. Cell & Gene Therapy Market, 2021 - 2033 (USD Billion)
4.10. Others
- 4.10.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 5. Oncology Drugs Market: Cancer Type Business Analysis

5.1. Cancer Type Market Share, 2025 & 2033
5.2. Cancer Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Cancer Type, 2021 to 2033 (USD Billion)
5.4. Solid Tumors
- 5.4.1. Solid Tumors Market, 2021 - 2033 (USD Billion)
5.5. Hematologic Malignancies
- 5.5.1. Hematologic Malignancies Market, 2021 - 2033 (USD Billion)

Chapter 6. Oncology Drugs Market: Route of Administration Business Analysis

6.1. Route of Administration Market Share, 2025 & 2033
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)
6.4. Oral
- 6.4.1. Oral Market, 2021 - 2033 (USD Billion)
6.5. Injectable
- 6.5.1. Injectable Market, 2021 - 2033 (USD Billion)
6.6. Others
- 6.6.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 7. Oncology Drugs Market: Drug Type Business Analysis

7.1. Drug Type Market Share, 2025 & 2033
7.2. Drug Type Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2021 to 2033 (USD Billion)
7.4. Branded
- 7.4.1. Branded Market, 2021 - 2033 (USD Billion)
7.5. Generic & Biosimilar
- 7.5.1. Generic & Biosimilar Market, 2021 - 2033 (USD Billion)

Chapter 8. Oncology Drugs Market: Distribution Channel Business Analysis

8.1. Distribution Channel Market Share, 2025 & 2033
8.2. Distribution Channel Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
8.4. Hospital Pharmacies
- 8.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
8.5. Retail Pharmacies
- 8.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
8.6. Online Pharmacies
- 8.6.1. Online Pharmacies Market, 2021 - 2033 (USD Billion)

Chapter 9. Oncology Drugs Market: Regional Estimates & Trend Analysis

9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
- 9.4.1. North America Oncology Drugs Market Estimates and Forecasts, By Country, 2021-2033 (USD Billion)
- 9.4.2. U.S.
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Target Disease Prevalence
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. Reimbursement Framework
  - 9.4.2.5. U.S. Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.4.3. Canada
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Target Disease Prevalence
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Reimbursement Framework
  - 9.4.3.5. Canada Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.4.4. Mexico
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Target Disease Prevalence
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. Reimbursement Framework
  - 9.4.4.5. Mexico Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
9.5. Europe
- 9.5.1. Europe Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.2. UK
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Target Disease Prevalence
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Reimbursement Framework
  - 9.5.2.5. UK Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.3. Germany
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Target Disease Prevalence
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. Reimbursement Framework
  - 9.5.3.5. Germany Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.4. France
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Target Disease Prevalence
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. Reimbursement Framework
  - 9.5.4.5. France Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.5. Italy
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Target Disease Prevalence
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Reimbursement Framework
  - 9.5.5.5. Italy Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.6. Spain
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Target Disease Prevalence
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Reimbursement Framework
  - 9.5.6.5. Spain Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.7. Denmark
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Target Disease Prevalence
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. Reimbursement Framework
  - 9.5.7.5. Denmark Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.8. Sweden
  - 9.5.8.1. Key Country Dynamics
  - 9.5.8.2. Target Disease Prevalence
  - 9.5.8.3. Regulatory Framework
  - 9.5.8.4. Reimbursement Framework
  - 9.5.8.5. Sweden Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.5.9. Norway
  - 9.5.9.1. Key Country Dynamics
  - 9.5.9.2. Target Disease Prevalence
  - 9.5.9.3. Regulatory Framework
  - 9.5.9.4. Reimbursement Framework
  - 9.5.9.5. Norway Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
9.6. Asia Pacific
- 9.6.1. Asia Pacific Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.6.2. Japan
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Target Disease Prevalence
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Reimbursement Framework
  - 9.6.2.5. Japan Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.6.3. China
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Target Disease Prevalence
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Reimbursement Framework
  - 9.6.3.5. China Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.6.4. India
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Target Disease Prevalence
  - 9.6.4.3. Regulatory Framework
  - 9.6.4.4. Reimbursement Framework
  - 9.6.4.5. India Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.6.5. Australia
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Target Disease Prevalence
  - 9.6.5.3. Regulatory Framework
  - 9.6.5.4. Reimbursement Framework
  - 9.6.5.5. Australia Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.6.6. South Korea
  - 9.6.6.1. Key Country Dynamics
  - 9.6.6.2. Target Disease Prevalence
  - 9.6.6.3. Regulatory Framework
  - 9.6.6.4. Reimbursement Framework
  - 9.6.6.5. South Korea Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.6.7. Thailand
  - 9.6.7.1. Key Country Dynamics
  - 9.6.7.2. Target Disease Prevalence
  - 9.6.7.3. Regulatory Framework
  - 9.6.7.4. Reimbursement Framework
  - 9.6.7.5. Thailand Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
9.7. Latin America
- 9.7.1. Latin America Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.7.2. Brazil
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Target Disease Prevalence
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. Reimbursement Framework
  - 9.7.2.5. Brazil Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.7.3. Argentina
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Target Disease Prevalence
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Reimbursement Framework
  - 9.7.3.5. Argentina Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
9.8. Middle East and Africa
- 9.8.1. Middle East and Africa Oncology Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 9.8.2. South Africa
  - 9.8.2.1. Key Country Dynamics
  - 9.8.2.2. Target Disease Prevalence
  - 9.8.2.3. Regulatory Framework
  - 9.8.2.4. Reimbursement Framework
  - 9.8.2.5. South Africa Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.8.3. Saudi Arabia
  - 9.8.3.1. Key Country Dynamics
  - 9.8.3.2. Target Disease Prevalence
  - 9.8.3.3. Regulatory Framework
  - 9.8.3.4. Reimbursement Framework
  - 9.8.3.5. Saudi Arabia Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.8.4. UAE
  - 9.8.4.1. Key Country Dynamics
  - 9.8.4.2. Target Disease Prevalence
  - 9.8.4.3. Regulatory Framework
  - 9.8.4.4. Reimbursement Framework
  - 9.8.4.5. UAE Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)
- 9.8.5. Kuwait
  - 9.8.5.1. Key Country Dynamics
  - 9.8.5.2. Target Disease Prevalence
  - 9.8.5.3. Regulatory Framework
  - 9.8.5.4. Reimbursement Framework
  - 9.8.5.5. Kuwait Oncology Drugs Market Estimates and Forecasts, 2021-2033 (USD Billion)

Chapter 10. Competitive Landscape

10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
- 10.5.1. Roche Holding AG
  - 10.5.1.1. Overview
  - 10.5.1.2. Financial Performance
  - 10.5.1.3. Product Benchmarking
  - 10.5.1.4. Strategic Initiatives
- 10.5.2. Merck & Co., Inc.
  - 10.5.2.1. Overview
  - 10.5.2.2. Financial Performance
  - 10.5.2.3. Product Benchmarking
  - 10.5.2.4. Strategic Initiatives
- 10.5.3. AstraZeneca PLC
  - 10.5.3.1. Overview
  - 10.5.3.2. Financial Performance
  - 10.5.3.3. Product Benchmarking
  - 10.5.3.4. Strategic Initiatives
- 10.5.4. Bristol Myers Squibb
  - 10.5.4.1. Overview
  - 10.5.4.2. Financial Performance
  - 10.5.4.3. Product Benchmarking
  - 10.5.4.4. Strategic Initiatives
- 10.5.5. Pfizer Inc.
  - 10.5.5.1. Overview
  - 10.5.5.2. Financial Performance
  - 10.5.5.3. Product Benchmarking
  - 10.5.5.4. Strategic Initiatives
- 10.5.6. Novartis AG
  - 10.5.6.1. Overview
  - 10.5.6.2. Financial Performance
  - 10.5.6.3. Product Benchmarking
  - 10.5.6.4. Strategic Initiatives
- 10.5.7. Johnson & Johnson
  - 10.5.7.1. Overview
  - 10.5.7.2. Financial Performance
  - 10.5.7.3. Product Benchmarking
  - 10.5.7.4. Strategic Initiatives
- 10.5.8. Eli Lilly and Company
  - 10.5.8.1. Overview
  - 10.5.8.2. Financial Performance
  - 10.5.8.3. Product Benchmarking
  - 10.5.8.4. Strategic Initiatives
- 10.5.9. GSK plc
  - 10.5.9.1. Overview
  - 10.5.9.2. Financial Performance
  - 10.5.9.3. Product Benchmarking
  - 10.5.9.4. Strategic Initiatives
- 10.5.10. Amgen Inc.
  - 10.5.10.1. Overview
  - 10.5.10.2. Financial Performance
  - 10.5.10.3. Product Benchmarking
  - 10.5.10.4. Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Oncology Drugs Market, By Region, 2021 - 2033 (USD Billion)
Table 4 Global Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 5 Global Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 6 Global Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 7 Global Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 8 Global Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 9 North America Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion)
Table 10 North America Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 11 North America Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 12 North America Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 13 North America Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 14 North America Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 15 U.S. Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 16 U.S. Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 17 U.S. Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 18 U.S Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 19 U.S Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 20 Canada Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 21 Canada Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 22 Canada Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 23 Canada Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 24 Canada Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 25 Mexico Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 26 Mexico Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 27 Mexico Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 28 Mexico Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 29 Mexico Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 30 Europe Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion)
Table 31 Europe Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 32 Europe Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 33 Europe Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 34 Europe Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 35 Europe Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 36 UK Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 37 UK Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 38 UK Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 39 UK Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 40 UK Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 41 Germany Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 42 Germany Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 43 Germany Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 44 Germany Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 45 Germany Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 46 France Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 47 France Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 48 France Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 49 France Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 50 France Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 51 Italy Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 52 Italy Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 53 Italy Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 54 Italy Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 55 Italy Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 56 Spain Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 57 Spain Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 58 Spain Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 59 Spain Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 60 Spain Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 61 Norway Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 62 Norway Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 63 Norway Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 64 Norway Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 65 Norway Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 66 Denmark Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 67 Denmark Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 68 Denmark Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 69 Denmark Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 70 Denmark Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 71 Sweden Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 72 Sweden Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 73 Sweden Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 74 Sweden Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 75 Sweden Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 76 Asia Pacific Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion)
Table 77 Asia Pacific Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 78 Asia Pacific Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 79 Asia Pacific Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 80 Asia Pacific Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 81 Asia Pacific Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 82 Japan Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 83 Japan Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 84 Japan Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 85 Japan Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 86 Japan Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 87 China Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 88 China Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 89 China Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 90 China Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 91 China Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 92 India Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 93 India Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 94 India Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 95 India Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 96 India Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 97 Australia Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 98 Australia Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 99 Australia Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 100 Australia Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 101 Australia Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 102 South Korea Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 103 South Korea Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 104 South Korea Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 105 South Korea Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 106 South Korea Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 107 Thailand Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 108 Thailand Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 109 Thailand Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 110 Thailand Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 111 Thailand Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 112 Latin America Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion)
Table 113 Latin America Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 114 Latin America Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 115 Latin America Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 116 Latin America Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 117 Latin America Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 118 Brazil Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 119 Brazil Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 120 Brazil Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 121 Brazil Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 122 Brazil Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 123 Argentina Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 124 Argentina Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 125 Argentina Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 126 Argentina Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 127 Argentina Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 128 Middle East & Africa Oncology Drugs Market, By Country, 2021 - 2033 (USD Billion)
Table 129 Middle East & Africa Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 130 Middle East & Africa Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 131 Middle East & Africa Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 132 Middle East & Africa Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 133 Middle East & Africa Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 134 South Africa Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 135 South Africa Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 136 South Africa Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 137 South Africa Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 138 South Africa Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 139 Saudi Arabia Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 140 Saudi Arabia Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 141 Saudi Arabia Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 142 Saudi Arabia Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 143 Saudi Arabia Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 144 UAE Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 145 UAE Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 146 UAE Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 147 UAE Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 148 UAE Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 149 Kuwait Oncology Drugs Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 150 Kuwait Oncology Drugs Market, By Cancer Type, 2021 - 2033 (USD Billion)
Table 151 Kuwait Oncology Drugs Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 152 Kuwait Oncology Drugs Market, By Drug Type, 2021 - 2033 (USD Billion)
Table 153 Kuwait Oncology Drugs Market, By Distribution Channel, 2021 - 2033 (USD Billion)